Nicholas J. Ede

551 total citations
27 papers, 437 citations indexed

About

Nicholas J. Ede is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Organic Chemistry. According to data from OpenAlex, Nicholas J. Ede has authored 27 papers receiving a total of 437 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 10 papers in Radiology, Nuclear Medicine and Imaging and 8 papers in Organic Chemistry. Recurrent topics in Nicholas J. Ede's work include Chemical Synthesis and Analysis (12 papers), Monoclonal and Polyclonal Antibodies Research (10 papers) and Gastric Cancer Management and Outcomes (5 papers). Nicholas J. Ede is often cited by papers focused on Chemical Synthesis and Analysis (12 papers), Monoclonal and Polyclonal Antibodies Research (10 papers) and Gastric Cancer Management and Outcomes (5 papers). Nicholas J. Ede collaborates with scholars based in Australia, Austria and India. Nicholas J. Ede's co-authors include Zemin Wu, David C. Jackson, Neil M. O’Brien‐Simpson, Lorena E. Brown, Geoffrey W. Tregear, Jim Haralambidis, Andrew M. Bray, Kade D. Roberts, John Swan and John N. Lambert and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Nicholas J. Ede

27 papers receiving 414 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nicholas J. Ede Australia	12	231	191	73	67	56	27	437
Nicole Nischan United States	14	562 2.4×	254 1.3×	57 0.8×	96 1.4×	64 1.1×	17	774
Ioannis Vrasidas Netherlands	9	355 1.5×	241 1.3×	174 2.4×	59 0.9×	68 1.2×	10	520
Niels Röckendorf Germany	11	238 1.0×	81 0.4×	48 0.7×	67 1.0×	19 0.3×	24	393
Maha Maglinao Germany	6	164 0.7×	88 0.5×	75 1.0×	32 0.5×	18 0.3×	7	290
Annika Groß Germany	14	216 0.9×	160 0.8×	99 1.4×	21 0.3×	260 4.6×	16	580
Baptiste Aussedat United States	16	581 2.5×	325 1.7×	78 1.1×	85 1.3×	28 0.5×	19	680
Sachin S. Shivatare Taiwan	11	427 1.8×	316 1.7×	85 1.2×	121 1.8×	24 0.4×	15	534
Stefania Ordanini Italy	10	212 0.9×	137 0.7×	91 1.2×	52 0.8×	21 0.4×	13	391
Robert A. Pon Canada	12	280 1.2×	169 0.9×	100 1.4×	72 1.1×	87 1.6×	21	461
W. Bloemhoff Netherlands	14	275 1.2×	80 0.4×	58 0.8×	149 2.2×	52 0.9×	25	444

Countries citing papers authored by Nicholas J. Ede

Since Specialization

Citations

This map shows the geographic impact of Nicholas J. Ede's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas J. Ede with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas J. Ede more than expected).

Fields of papers citing papers by Nicholas J. Ede

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas J. Ede. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas J. Ede. The network helps show where Nicholas J. Ede may publish in the future.

Co-authorship network of co-authors of Nicholas J. Ede

This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas J. Ede. A scholar is included among the top collaborators of Nicholas J. Ede based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas J. Ede. Nicholas J. Ede is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tobias, Joshua, Sandra Högler, Yee Chao, et al.. (2023). Preclinical and Clinical Observations Implying Combination Therapy to Enhance the Efficacy of the Her-2/neu B-Cell Peptide-Based Vaccine HER-Vaxx and to Prevent Immune Evasion. International Journal of Molecular Sciences. 25(1). 287–287. 1 indexed citations

Price, Timothy, et al.. (2023). nextHERIZON: A phase 2 study of HER-Vaxx, a HER2-targeting peptide vaccine, in combination with chemotherapy or pembrolizumab in patients with HER2 metastatic or advanced gastric/gastroesophageal adenocarcinoma that progressed on or after trastuzumab treatment.. Journal of Clinical Oncology. 41(4_suppl). TPS481–TPS481. 1 indexed citations

Andrić, Zoran, Iurie Bulat, Rajnish Nagarkar, et al.. (2023). HERIZON: A phase 2 study of HER-Vaxx (IMU-131), a HER2-targeting peptide vaccine, plus standard of care chemotherapy in patients with HER2-overexpressing metastatic or advanced gastric/GEJ adenocarcinoma— Overall survival analysis.. Journal of Clinical Oncology. 41(4_suppl). 289–289. 10 indexed citations

Tobias, Joshua, et al.. (2023). 1536P HERIZON: A phase II study of HER-Vaxx (IMU-131), a HER2-targeting peptide vaccine plus standard of care chemotherapy in patients with HER2+ advanced stomach cancer - Dose-dependent anti-cancer antibodies correlating with improved clinical outcome. Annals of Oncology. 34. S864–S864. 2 indexed citations

Tobias, Joshua, Michael Kundi, Erika Garner‐Spitzer, et al.. (2023). PD-8 HERIZON: A phase 2 study of HER-Vaxx (IMU-131), a HER2-targeting peptide vaccine plus SOC chemotherapy in patients with HER2+ advanced stomach cancer – correlation of the antibody responses and clinical outcome. Annals of Oncology. 34. S4–S4. 4 indexed citations

Guo, Linlin, Jay Overholser, Anthony J. Good, Nicholas J. Ede, & Pravin T. P. Kaumaya. (2022). Preclinical Studies of a Novel Human PD-1 B-Cell Peptide Cancer Vaccine PD1-Vaxx From BALB/c Mice to Beagle Dogs and to Non-Human Primates (Cynomolgus Monkeys). Frontiers in Oncology. 12. 826566–826566. 16 indexed citations

Chaurasiya, Shyambabu, Annie Yang, Zhifang Zhang, et al.. (2021). A comprehensive preclinical study supporting clinical trial of oncolytic chimeric poxvirus CF33-hNIS-anti-PD-L1 to treat breast cancer. Molecular Therapy — Methods & Clinical Development. 24. 102–116. 5 indexed citations

Bulat, Iurie, Zoran Andrić, Davorin Radosavljević, et al.. (2021). P-159 HERIZON: Phase 2 part of the IMU-131 HER2/neu vaccine plus chemotherapy study randomized in patients with HER2/NEU overexpressing metastatic or advanced adenocarcinoma of the stomach or gastroesophageal junction. Annals of Oncology. 32. S154–S154. 1 indexed citations

Bulat, Iurie, Zoran Andrić, Rajnish Nagarkar, et al.. (2021). Abstract CT107: A PHASE 1B/2 OPEN-LABEL STUDY WITH RANDOMIZATION IN PHASE 2 OF IMU-131 HER2/NEU PEPTIDE VACCINE PLUS STANDARD OF CARE CHEMOTHERAPY IN PATIENTS WITH HER2/NEU OVEREXPRESSING METASTATIC OR ADVANCED ADENOCARCINOMA OF THE STOMACH OR GASTROESOPHAGEAL JUNCTION. Cancer Research. 81(13_Supplement). CT107–CT107. 4 indexed citations

10.

Wiedermann, Ursula, Erika Garner‐Spitzer, Yee Chao, et al.. (2019). Comprehensive results of a phase Ib study with a HER2/neu B-cell peptide vaccine administered with cisplatin and 5-fluorouracil or capecitabine chemotherapy show safety, immunogenicity and clinical response in patients with HER2/Neu overexpressing advanced gastric cancer. Annals of Oncology. 30. v495–v496. 2 indexed citations

11.

Tobias, Joshua, Joanna Jasińska, Karin Baier, et al.. (2017). Enhanced and long term immunogenicity of a Her-2/neu multi-epitope vaccine conjugated to the carrier CRM197 in conjunction with the adjuvant Montanide. BMC Cancer. 17(1). 118–118. 29 indexed citations

12.

Roberts, Kade D. & Nicholas J. Ede. (2007). Examination of methodology for the synthesis of cyclic thioether peptide libraries derived from linear tripeptides. Journal of Peptide Science. 13(12). 811–821. 9 indexed citations

13.

Ede, Nicholas J., et al.. (2004). A Convenient Solid Phase Synthesis of Disubstituted Guanidines. QSAR & Combinatorial Science. 23(8). 655–661. 1 indexed citations

14.

Pei, Yazhong, David J. Owen, Lawrence J. D’Souza, et al.. (2002). Efficient Syntheses of Benzothiazepines as Antagonists for the Mitochondrial Sodium−Calcium Exchanger: Potential Therapeutics for Type II Diabetes. The Journal of Organic Chemistry. 68(1). 92–103. 42 indexed citations

15.

Rousselot‐Pailley, Pierre, Nicholas J. Ede, & Guy Lippens. (2001). Monitoring of Solid-Phase Organic Synthesis on Macroscopic Supports by High-Resolution Magic Angle Spinning NMR. Journal of Combinatorial Chemistry. 3(6). 559–563. 18 indexed citations

16.

Wu, Zemin & Nicholas J. Ede. (2001). Solid-phase synthesis of quinoxalines on SynPhase™ Lanterns. Tetrahedron Letters. 42(45). 8115–8118. 83 indexed citations

17.

Bui, Chinh T., Francesca Ercole, Rhonda Campbell, et al.. (2000). Improving the performance of an acid-labile 4-hydroxymethyl phenoxyacetic acid (HMP) linker on resin and SynPhase? grafted solid-supports. Journal of Peptide Science. 6(10). 534–538. 4 indexed citations

18.

Roberts, Kade D., John N. Lambert, Nicholas J. Ede, & Andrew M. Bray. (1998). Efficient synthesis of thioether-based cyclic peptide libraries. Tetrahedron Letters. 39(45). 8357–8360. 28 indexed citations

19.

Jackson, David C., Neil M. O’Brien‐Simpson, Nicholas J. Ede, & Lorena E. Brown. (1997). Free radical induced polymerization of synthetic peptides into polymeric immunogens. Vaccine. 15(15). 1697–1705. 39 indexed citations

20.

Ede, Nicholas J., Geoffrey W. Tregear, & Jim Haralambidis. (1994). Routine Preparation of Thiol Oligonucleotides: Application to the Synthesis of Oligonucleotide-Peptide Hybrids. Bioconjugate Chemistry. 5(4). 373–378. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact